Intensified Treatment With Carfilzomib in Myeloma Patients Still PET-positive After First Line Treatment.

NCT03314636 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

53

Enrollment

OTHER

Sponsor class

Conditions

Myeloma

Interventions

DRUG: Carfilzomib
DRUG: Lenalidomide
DEVICE: PET-CT
DRUG: Dexamethasone

Sponsor

Oslo University Hospital

Collaborators

[object Object]